Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Crown

Showing results (1-10 of 202) with videos related to

Pageof 21
Sort By:
Lancet (London, England)|October 12, 2004
Smart bombs versus blunderbusses: high-dose chemotherapy for breast cancerJohn Crown
Lancet (London, England)|September 6, 2003
Chemotherapy dose and schedule in adjuvant treatment of breast cancer: phoenix, turkey, or dodo?John Crown
Oncotarget|February 18, 2017
CDK8: a new breast cancer targetJohn Crown
Anticancer Research|June 28, 2007
EGFR and HER-2 antagonists in breast cancerNorma O'Donovan, John Crown
Breast Cancer Research and Treatment|July 19, 2003
Platinum-taxane combinations in metastatic breast cancer: an evolving role in the era of molecularly targeted therapyJohn Crown, Mark Pegram
International Journal of Cancer|July 9, 2020
Drugging "undruggable" genes for cancer treatment: Are we making progress?Michael J Duffy, John Crown
Clinical Chemistry|August 13, 2022
Circulating Tumor DNA as a Biomarker for Monitoring Patients with Solid Cancers: Comparison with Standard Protein BiomarkersMichael J Duffy, John Crown
Critical Reviews in Clinical Laboratory Sciences|January 18, 2014
Precision treatment for cancer: role of prognostic and predictive markersMichael J Duffy, John Crown
Clinical Chemistry|July 19, 2019
Biomarkers for Predicting Response to Immunotherapy with Immune Checkpoint Inhibitors in Cancer PatientsMichael J Duffy, John Crown
Journal of Personalized Medicine|January 21, 2022
Use of Circulating Tumour DNA (ctDNA) for Measurement of Therapy Predictive Biomarkers in Patients with CancerMichael J Duffy, John Crown
Pageof 21

Showing results (1-10 of 202) with videos related to

Sort By:
Pageof 21
Lancet (London, England)|October 12, 2004
Smart bombs versus blunderbusses: high-dose chemotherapy for breast cancerJohn Crown
Lancet (London, England)|September 6, 2003
Chemotherapy dose and schedule in adjuvant treatment of breast cancer: phoenix, turkey, or dodo?John Crown
Oncotarget|February 18, 2017
CDK8: a new breast cancer targetJohn Crown
Anticancer Research|June 28, 2007
EGFR and HER-2 antagonists in breast cancerNorma O'Donovan, John Crown
Breast Cancer Research and Treatment|July 19, 2003
Platinum-taxane combinations in metastatic breast cancer: an evolving role in the era of molecularly targeted therapyJohn Crown, Mark Pegram
International Journal of Cancer|July 9, 2020
Drugging "undruggable" genes for cancer treatment: Are we making progress?Michael J Duffy, John Crown
Clinical Chemistry|August 13, 2022
Circulating Tumor DNA as a Biomarker for Monitoring Patients with Solid Cancers: Comparison with Standard Protein BiomarkersMichael J Duffy, John Crown
Critical Reviews in Clinical Laboratory Sciences|January 18, 2014
Precision treatment for cancer: role of prognostic and predictive markersMichael J Duffy, John Crown
Clinical Chemistry|July 19, 2019
Biomarkers for Predicting Response to Immunotherapy with Immune Checkpoint Inhibitors in Cancer PatientsMichael J Duffy, John Crown
Journal of Personalized Medicine|January 21, 2022
Use of Circulating Tumour DNA (ctDNA) for Measurement of Therapy Predictive Biomarkers in Patients with CancerMichael J Duffy, John Crown
Pageof 21